{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:40:03Z","timestamp":1792658403933,"version":"4.5.0"},"reference-count":172,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2094,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.fertnstert.2016.08.023","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T20:15:44Z","timestamp":1471983344000},"page":"967-977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Endocrine-disrupting chemicals and uterine fibroids"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0220-1781","authenticated-orcid":false,"given":"Tiffany A.","family":"Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey S.","family":"Trevi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl Lyn","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Al-Hendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2016.08.023_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.EDE.0000054360.61254.27","article-title":"Why is parity protective for uterine fibroids?","volume":"14","author":"Baird","year":"2003","journal-title":"Epidemiology"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2013.08.008","article-title":"The health disparities of uterine fibroid tumors for African American women: a public health issue","volume":"210","author":"Eltoukhi","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib3","first-page":"625","article-title":"The impact of endometrial ablation on hysterectomy rates in women with benign uterine conditions in the United States","volume":"18","author":"Farquhar","year":"2002","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1089\/jwh.2005.14.692","article-title":"The economic impact of uterine fibroids in the United States: a summary of published estimates","volume":"14","author":"Mauskopf","year":"2005","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib5","doi-asserted-by":"crossref","first-page":"211.e1","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1177\/1933719114546644","article-title":"Uterine fibroid research: a work in progress","volume":"21","author":"Segars","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib7","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/humrep\/16.11.2411","article-title":"A prospective controlled study of the effect of intramural uterine fibroids on the outcome of assisted conception","volume":"16","author":"Hart","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humupd\/dmt058","article-title":"Proceedings from the third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations","volume":"20","author":"Segars","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib9","first-page":"182","article-title":"Obstetric characteristics and perinatal outcome of pregnancies with uterine leiomyomas","volume":"49","author":"Sheiner","year":"2004","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0015-0282(00)01714-3","article-title":"Impact of intramural leiomyomata in patients with a normal endometrial cavity on in\u00a0vitro fertilization\u2013embryo transfer cycle outcome","volume":"75","author":"Surrey","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib11","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1289\/ehp.5787","article-title":"Etiology and pathogenesis of uterine leiomyomas: a review","volume":"111","author":"Flake","year":"2003","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0030-1251477","article-title":"New directions in the epidemiology of uterine fibroids","volume":"28","author":"Laughlin","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib13","first-page":"90","article-title":"Association of race, age and body mass index with gross pathology of uterine fibroids","volume":"53","author":"Moore","year":"2008","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib14","doi-asserted-by":"crossref","first-page":"19887","DOI":"10.1073\/pnas.0808188105","article-title":"Growth of uterine leiomyomata among premenopausal black and white women","volume":"105","author":"Peddada","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib15","first-page":"1","article-title":"Management of uterine fibroids: an update of the evidence","author":"Viswanathan","year":"2007","journal-title":"Evid Rep Technol Assess (Full Rep)"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.whi.2009.03.001","article-title":"Racial differences in women who have a hysterectomy for benign conditions","volume":"19","author":"Weiss","year":"2009","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/aje\/kwh017","article-title":"Invited commentary: uterine leiomyomata-we know so little but could learn so much","volume":"159","author":"Baird","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/AOG.0b013e318197bbaf","article-title":"Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study","volume":"113","author":"Laughlin","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib19","first-page":"202","article-title":"Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25\u201340 years","volume":"79","author":"Borgfeldt","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/aje\/kwm048","article-title":"Serum dioxin concentrations and risk of uterine leiomyoma in the Seveso Women\u2019s Health Study","volume":"166","author":"Eskenazi","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1089\/jwh.2015.5277","article-title":"A prospective, ultrasound-based study to evaluate risk factors for uterine fibroid incidence and growth: methods and results of recruitment","volume":"24","author":"Baird","year":"2015","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cancergencyto.2010.06.010","article-title":"Cell culture and senescence in uterine fibroids","volume":"202","author":"Markowski","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/gcc.20777","article-title":"HMGA2 and the p19Arf-TP53-CDKN1A axis: a delicate balance in the growth of uterine leiomyomas","volume":"49","author":"Markowski","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib24","doi-asserted-by":"crossref","first-page":"966","DOI":"10.18632\/oncotarget.370","article-title":"MED12 exon 2 mutations are common in uterine leiomyomas from South African patients","volume":"2","author":"Makinen","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1126\/science.1208930","article-title":"MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas","volume":"334","author":"Makinen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib26","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/ijc.28410","article-title":"Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas","volume":"134","author":"Makinen","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib27","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/ejhg.2013.33","article-title":"MED12 exon 2 mutations in histopathological uterine leiomyoma variants","volume":"21","author":"Makinen","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib28","doi-asserted-by":"crossref","first-page":"e33251","DOI":"10.1371\/journal.pone.0033251","article-title":"Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas","volume":"7","author":"McGuire","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib29","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Multiple Leiomyoma Consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","volume":"73","author":"Toro","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib31","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1001\/archdermatol.2008.517","article-title":"Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer","volume":"144","author":"Stewart","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib32","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1210\/er.2015-1010","article-title":"EDC-2: The Endocrine Society\u2019s Second Scientific Statement on Endocrine-Disrupting Chemicals","volume":"36","author":"Gore","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib33","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1210\/endo.139.10.6216","article-title":"Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta","volume":"139","author":"Kuiper","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/bph.12122","article-title":"Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells","volume":"169","author":"Sengupta","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jb\/mvm158","article-title":"Structural evidence for endocrine disruptor bisphenol A binding to human nuclear receptor ERR gamma","volume":"142","author":"Matsushima","year":"2007","journal-title":"J Biochem"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1289\/ehp.1104426","article-title":"Bisphenol A and its analogues activate human pregnane X receptor","volume":"120","author":"Sui","year":"2012","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/toxsci\/kfq379","article-title":"Estrogen-like activity of perfluoroalkyl acids in\u00a0vivo and interaction with human and rainbow trout estrogen receptors in\u00a0vitro","volume":"120","author":"Benninghoff","year":"2011","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jat.1736","article-title":"Comparison of in\u00a0vitro cytotoxicity, estrogenicity and anti-estrogenicity of triclosan, perfluorooctane sulfonate and perfluorooctanoic acid","volume":"33","author":"Henry","year":"2013","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib39","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1289\/ehp.95103582","article-title":"A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic","volume":"103","author":"Jobling","year":"1995","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib40","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1073\/pnas.75.1.468","article-title":"Estrogenic activity in\u00a0vivo and in\u00a0vitro of some diethylstilbestrol metabolites and analogs","volume":"75","author":"Korach","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.reprotox.2014.12.014","article-title":"Hypothesis: activation of rapid signaling by environmental estrogens and epigenetic reprogramming in breast cancer","volume":"54","author":"Trevino","year":"2015","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fphar.2016.00040","article-title":"Early life adverse environmental exposures increase the risk of uterine fibroid development: role of epigenetic regulation","volume":"7","author":"Yang","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.toxlet.2014.01.035","article-title":"Involvement of activating ERK1\/2 through G protein coupled receptor 30 and estrogen receptor alpha\/beta in low doses of bisphenol A promoting growth of Sertoli TM4 cells","volume":"226","author":"Ge","year":"2014","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib44","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1210\/en.2013-1955","article-title":"Bisphenol A promotes human prostate stem-progenitor cell self-renewal and increases in\u00a0vivo carcinogenesis in human prostate epithelium","volume":"155","author":"Prins","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib45","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1289\/ehp.1103781","article-title":"Low concentrations of bisphenol A induce mouse spermatogonial cell proliferation by G protein-coupled receptor 30 and estrogen receptor-alpha","volume":"119","author":"Sheng","year":"2011","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib46","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1289\/ehp.7175","article-title":"Xenoestrogen-induced ERK-1 and ERK-2 activation via multiple membrane-initiated signaling pathways","volume":"112","author":"Bulayeva","year":"2004","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.envpol.2010.09.004","article-title":"Bisphenol A induces a rapid activation of Erk1\/2 through GPR30 in human breast cancer cells","volume":"159","author":"Dong","year":"2011","journal-title":"Environ Pollut"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib48","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jsbmb.2005.08.018","article-title":"Activation of kinase pathways in MCF-7 cells by 17beta-estradiol and structurally diverse estrogenic compounds","volume":"98","author":"Li","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib49","doi-asserted-by":"crossref","first-page":"16043","DOI":"10.1038\/nrdp.2016.43","article-title":"Uterine fibroids","volume":"2","author":"Stewart","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib50","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"Bulun","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1933719115584449","article-title":"The mechanism and function of epigenetics in uterine leiomyoma development","volume":"23","author":"Yang","year":"2015","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib52","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fertnstert.2013.03.007","article-title":"Complex networks of multiple factors in the pathogenesis of uterine leiomyoma","volume":"100","author":"Islam","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.molcel.2007.05.026","article-title":"CDK8 is a stimulus-specific positive coregulator of p53 target genes","volume":"27","author":"Donner","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib54","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00438-014-0938-x","article-title":"Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids","volume":"290","author":"Halder","year":"2015","journal-title":"Mol Genet Genomics"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib55","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/ijc.27424","article-title":"MED12 mutations in uterine fibroids\u2014their relationship to cytogenetic subgroups","volume":"131","author":"Markowski","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib56","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/humu.22612","article-title":"Mutations in exon 1 highlight the role of MED12 in uterine leiomyomas","volume":"35","author":"Kampjarvi","year":"2014","journal-title":"Hum Mutat"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/dmu048","article-title":"Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications","volume":"21","author":"Moravek","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib58","doi-asserted-by":"crossref","first-page":"14783","DOI":"10.1073\/pnas.192569699","article-title":"Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src\/Erk phosphorylation cascade","volume":"99","author":"Wong","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib59","doi-asserted-by":"crossref","first-page":"F358","DOI":"10.1152\/ajprenal.00343.2011","article-title":"17\u03b2-Estradiol induces nongenomic effects in renal intercalated cells through G protein-coupled estrogen receptor 1","volume":"302","author":"Hofmeister","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib60","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/me.2004-0486","article-title":"Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes","volume":"19","author":"Bjornstrom","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib61","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1210\/me.2002-0072","article-title":"Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions","volume":"16","author":"Bjornstrom","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib62","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1073\/pnas.96.8.4686","article-title":"Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium","volume":"96","author":"Improta-Brears","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib63","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1210\/en.2003-0495","article-title":"Short-term activation by low 17\u03b2-estradiol concentrations of the Na+\/H+ exchanger in rat aortic smooth muscle cells: physiopathological implications","volume":"144","author":"Incerpi","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib64","doi-asserted-by":"crossref","first-page":"7460","DOI":"10.1074\/jbc.M411565200","article-title":"Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells","volume":"280","author":"Klinge","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib65","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2174\/138920206779315737","article-title":"Estrogen signaling multiple pathways to impact gene transcription","volume":"7","author":"Marino","year":"2006","journal-title":"Curr Genom"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib66","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/35035131","article-title":"Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase","volume":"407","author":"Simoncini","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib67","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1124\/pr.114.009712","article-title":"International Union of Basic and Clinical Pharmacology. XCVII. G protein-coupled estrogen receptor and its pharmacologic modulators","volume":"67","author":"Prossnitz","year":"2015","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib68","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1196\/annals.1286.001","article-title":"Estrogen modulation of G-protein-coupled receptor activation of potassium channels in the central nervous system","volume":"1007","author":"Kelly","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib69","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00204-012-0868-5","article-title":"Estrogen receptors and human disease: an update","volume":"86","author":"Burns","year":"2012","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib70","doi-asserted-by":"crossref","first-page":"E572","DOI":"10.1210\/jc.2014-4011","article-title":"1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells","volume":"100","author":"Al-Hendy","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib71","first-page":"3915","article-title":"p53 Tumor suppressor protein content in human uterine leiomyomas and its down-regulation by 17 beta-estradiol","volume":"87","author":"Gao","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib72","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/molehr\/6.1.55","article-title":"Tissue differences but limited sex steroid responsiveness of c-fos and c-jun in human fibroids and myometrium","volume":"6","author":"Gustavsson","year":"2000","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib73","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/0002-9378(93)90293-R","article-title":"Expression of connexin-43 in human myometrium and leiomyoma","volume":"169","author":"Andersen","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib74","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/1097-4652(2000)9999:999<000::AID-JCP1040>3.0.CO;2-E","article-title":"17-\u03b2 Estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway","volume":"186","author":"Barbarisi","year":"2001","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib75","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1210\/en.2008-0224","article-title":"Human uterine smooth muscle and leiomyoma cells differ in their rapid 17\u03b2-estradiol signaling: implications for proliferation","volume":"150","author":"Nierth-Simpson","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib76","first-page":"921","article-title":"17\u03b2-Estradiol induces up-regulation of PTEN and PPAR\u03b3 in leiomyoma cells, but not in normal cells","volume":"36","author":"Jeong","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib77","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/molehr\/gah174","article-title":"Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines","volume":"11","author":"Swartz","year":"2005","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib78","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.fertnstert.2015.04.024","article-title":"Increased progesterone receptor expression in uterine leiomyoma: correlation with age,\u00a0number of leiomyomas, and clinical symptoms","volume":"104","author":"Tsigkou","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib79","first-page":"293","article-title":"Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone","volume":"82","author":"Matsuo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib80","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/jc.2008-2093","article-title":"Progestins activate the AKT pathway in leiomyoma cells and promote survival","volume":"94","author":"Hoekstra","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib81","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1210\/jc.2009-1286","article-title":"Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells","volume":"94","author":"Luo","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib82","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1158\/0008-5472.CAN-09-2612","article-title":"Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells","volume":"70","author":"Yin","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib83","first-page":"2192","article-title":"Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma","volume":"83","author":"Shimomura","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib84","doi-asserted-by":"crossref","first-page":"17053","DOI":"10.1073\/pnas.1313650110","article-title":"Paracrine activation of WNT\/beta-catenin pathway in uterine leiomyoma stem cells promotes tumor growth","volume":"110","author":"Ono","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib85","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/gcc.20415","article-title":"A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas","volume":"46","author":"Wang","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib86","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.fertnstert.2007.05.074","article-title":"Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium","volume":"89","author":"Marsh","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib87","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1210\/jc.2015-3555","article-title":"Vitamin D3 inhibits Wnt\/\u03b2-catenin and mTOR signaling pathways in human uterine fibroid cells","volume":"101","author":"Al-Hendy","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib88","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/humrep\/det265","article-title":"Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells","volume":"28","author":"Halder","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib89","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1210\/jc.2010-2131","article-title":"1,25-Dihydroxyvitamin D3 reduces TGF-\u03b23-induced fibrosis-related gene expression in human uterine leiomyoma cells","volume":"96","author":"Halder","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib90","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/cbt.5.1.2234","article-title":"Expression and functional analysis of platelet-derived growth factor in uterine leiomyomata","volume":"5","author":"Liang","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib91","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejogrb.2006.01.034","article-title":"Transforming growth factor beta and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumour growth","volume":"130","author":"Wola\u0144ska","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib92","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0015-0282(00)00418-0","article-title":"Transforming growth factor-\u03b23 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation","volume":"73","author":"Arici","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib93","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fertnstert.2012.04.002","article-title":"2-Methoxyestradiol causes functional repression of transforming growth factor \u03b23 signaling by ameliorating Smad and non-Smad signaling pathways in immortalized uterine fibroid cells","volume":"98","author":"Salama","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib94","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jcem.86.11.8008","article-title":"Up-regulation by IGF-I of proliferating cell nuclear antigen and Bcl-2 protein expression in human uterine leiomyoma cells","volume":"86","author":"Gao","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib95","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.fertnstert.2007.10.083","article-title":"Expression of insulin-like growth factors (IGFs) and IGF signaling: molecular complexity in uterine leiomyomas","volume":"91","author":"Peng","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib96","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2119\/2007-00101.YU","article-title":"Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas","volume":"14","author":"Yu","year":"2008","journal-title":"Mol Med"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib97","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1210\/jc.2015-2935","article-title":"Circulating sex hormones and risk of uterine fibroids: Study of Women\u2019s Health Across the Nation (SWAN)","volume":"101","author":"Wong","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib98","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/1933719115602771","article-title":"In\u00a0vivo evidence of the androgen receptor in association with myometrial cell proliferation and apoptosis","volume":"23","author":"Lan","year":"2016","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib99","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2004-828618","article-title":"Potential nonhormonal therapeutics for medical treatment of leiomyomas","volume":"22","author":"Young","year":"2004","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib100","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/humrep\/den083","article-title":"Retinoids regulate genes involved in retinoic acid synthesis and transport in human myometrial and fibroid smooth muscle cells","volume":"23","author":"Zaitseva","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib101","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0033-1348896","article-title":"Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma","volume":"31","author":"Catherino","year":"2013","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib102","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.fertnstert.2012.07.1132","article-title":"Leiomyoma fibrosis inhibited by liarozole, a retinoic acid metabolic blocking agent","volume":"98","author":"Gilden","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib103","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2265.2008.03207.x","article-title":"Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells","volume":"69","author":"Malik","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib104","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.fertnstert.2006.11.093","article-title":"Uterine leiomyomas express a molecular pattern that lowers retinoic acid exposure","volume":"87","author":"Catherino","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib105","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/j.1460-2075.1990.tb08280.x","article-title":"Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B","volume":"9","author":"Kastner","year":"1990","journal-title":"EMBO J"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib106","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fnins.2013.00159","article-title":"Non-genomic mechanisms of progesterone action in the brain","volume":"7","author":"Singh","year":"2013","journal-title":"Front Neurosci"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib107","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/humupd\/dmu056","article-title":"Role of nuclear progesterone receptor isoforms in uterine pathophysiology","volume":"21","author":"Patel","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib108","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1097-2765(01)00304-5","article-title":"Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases","volume":"8","author":"Boonyaratanakornkit","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib109","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.steroids.2010.09.006","article-title":"Membrane progesterone receptor expression in mammalian tissues: a review of regulation and physiological implications","volume":"76","author":"Dressing","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib110","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1210\/me.2007-0437","article-title":"Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors","volume":"22","author":"Faivre","year":"2008","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib111","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/emboj\/17.7.2008","article-title":"Activation of the Src\/p21ras\/Erk pathway by progesterone receptor via cross-talk with estrogen receptor","volume":"17","author":"Migliaccio","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib112","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/humrep\/deh146","article-title":"Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells","volume":"19","author":"Yamada","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib113","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/GCO.0000000000000082","article-title":"Selective progesterone receptor modulators","volume":"26","author":"Whitaker","year":"2014","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib114","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib115","first-page":"1","article-title":"Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies","author":"Wagenfeld","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib116","first-page":"48","article-title":"Long-term intermittent pharmacological therapy of uterine fibroids\u2014a possibility to avoid hysterectomy\u00a0and its negative consequences","volume":"15","author":"Olejek","year":"2016","journal-title":"Prz Menopauzalny"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib117","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1358\/dot.2015.51.11.2413469","article-title":"Ulipristal acetate for uterine fibroid-related symptoms","volume":"51","author":"Puchar","year":"2015","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib118","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1517\/13543784.2015.1076791","article-title":"Investigational hormone receptor agonists as ongoing female contraception: a focus on selective progesterone receptor modulators in early clinical development","volume":"24","author":"Nelson","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib119","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/GCO.0000000000000229","article-title":"Current management of myomas: the place of medical therapy with the advent of selective progesterone receptor modulators","volume":"27","author":"Donnez","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib120","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib121","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1126\/science.150.3692.67","article-title":"Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas","volume":"150","author":"Linder","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib122","doi-asserted-by":"crossref","first-page":"18700","DOI":"10.1073\/pnas.0704472104","article-title":"Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells","volume":"104","author":"Ono","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib123","doi-asserted-by":"crossref","first-page":"e36935","DOI":"10.1371\/journal.pone.0036935","article-title":"Role of stem cells in human uterine leiomyoma growth","volume":"7","author":"Ono","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib124","first-page":"431","article-title":"An adult myometrial pluripotential precursor that promotes healing of damaged muscular tissues","volume":"24","author":"Galvez","year":"2010","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib125","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.mehy.2011.08.026","article-title":"Hypoxia: the driving force of uterine myometrial stem cells differentiation into leiomyoma cells","volume":"77","author":"Zhou","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib126","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1933719109348924","article-title":"Uterine leiomyomas exhibit fewer stem\/progenitor cell characteristics when compared with corresponding normal myometrium","volume":"17","author":"Chang","year":"2010","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib127","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.fertnstert.2012.04.044","article-title":"Identification and characterization of the human leiomyoma side population as putative tumor-initiating cells","volume":"98","author":"Mas","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib128","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-0032-1331801","article-title":"Somatic stem cells in the myometrium and in myomas","volume":"31","author":"Maruyama","year":"2013","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib129","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.fertnstert.2014.04.051","article-title":"Current understanding of somatic stem cells in leiomyoma formation","volume":"102","author":"Mas","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib130","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1172\/JCI81534","article-title":"Med12 gain-of-function mutation causes leiomyomas and genomic instability","volume":"125","author":"Mittal","year":"2015","journal-title":"J Clin Investig"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib131","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1095\/biolreprod.114.123794","article-title":"Tissue-specific stem cells in the myometrium and tumor-initiating cells in leiomyoma","volume":"91","author":"Ono","year":"2014","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib132","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1634\/stemcells.2006-0204","article-title":"Adult mouse myometrial label-retaining cells divide in response to gonadotropin stimulation","volume":"25","author":"Szotek","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib133","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1095\/biolreprod.109.081158","article-title":"Stretch-induced uterine myocyte differentiation during rat pregnancy: involvement of caspase activation","volume":"82","author":"Shynlova","year":"2010","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib134","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.fertnstert.2015.04.021","article-title":"Stro-1\/CD44 as putative human myometrial and fibroid stem cell markers","volume":"104","author":"Mas","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib135","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1158\/1078-0432.CCR-13-2491","article-title":"Molecular pathways: epigenetic modulation of Wnt\/glycogen synthase kinase-3 signaling to target human cancer stem cells","volume":"20","author":"Benoit","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib136","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.reprotox.2005.01.002","article-title":"Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development","volume":"20","author":"Baird","year":"2005","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib137","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1289\/ehp.0901423","article-title":"Association of intrauterine and early-life exposures with diagnosis of uterine leiomyomata by 35 years of age in the Sister Study","volume":"118","author":"D\u2019Aloisio","year":"2010","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib138","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1289\/ehp.1103620","article-title":"Early-life exposures and early-onset uterine leiomyomata in black women in the Sister Study","volume":"120","author":"D\u2019Aloisio","year":"2012","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib139","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/aje\/kwt250","article-title":"Prenatal diethylstilbestrol exposure and risk of uterine leiomyomata in the Nurses\u2019 Health Study II","volume":"179","author":"Mahalingaiah","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000147839.74848.7c","article-title":"Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure","volume":"105","author":"Wise","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib141","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng0195-70","article-title":"A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer","volume":"9","author":"Kobayashi","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib142","doi-asserted-by":"crossref","first-page":"11413","DOI":"10.1073\/pnas.91.24.11413","article-title":"Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene","volume":"91","author":"Yeung","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib143","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/gcc.10281","article-title":"Uterine leiomyoma in the Eker rat: a unique model for important diseases of women","volume":"38","author":"Walker","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib144","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1095\/biolreprod63.5.1322","article-title":"Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat","volume":"63","author":"Burroughs","year":"2000","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib145","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1093\/carcin\/22.12.2049","article-title":"Protective effect of pregnancy for development of uterine leiomyoma","volume":"22","author":"Walker","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib146","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1749-6632.2001.tb03991.x","article-title":"An in\u00a0vivo\/in\u00a0vitro model to assess endocrine disrupting activity of xenoestrogens in uterine leiomyoma","volume":"948","author":"Hodges","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib147","first-page":"1568","article-title":"Rodent model of reproductive tract leiomyomata: establishment and characterization of tumor-derived cell lines","volume":"146","author":"Howe","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib148","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1098-2744(199611)17:3<151::AID-MC7>3.0.CO;2-I","article-title":"Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators","volume":"17","author":"Fuchs-Young","year":"1996","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib149","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/107155760000700410","article-title":"Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma","volume":"7","author":"Walker","year":"2000","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.fertnstert.2003.06.009","article-title":"Raloxifene prevents the growth of uterine leiomyomas in premenopausal women","volume":"81","author":"Jirecek","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib151","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.fertnstert.2004.12.058","article-title":"Antiproliferative and proapoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women","volume":"84","author":"Palomba","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib152","first-page":"3766","article-title":"Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function","volume":"62","author":"Hunter","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib153","first-page":"4049","article-title":"Presence of an insulin-like growth factor I autocrine loop predicts uterine fibroid responsiveness to tamoxifen","volume":"56","author":"Howe","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib154","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/modpathol.3800283","article-title":"Expression profile of tuberin and some potential tumorigenic factors in 60 patients with uterine leiomyomata","volume":"18","author":"Wei","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib155","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1210\/me.2013-1059","article-title":"Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs","volume":"27","author":"Prizant","year":"2013","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib156","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/molehr\/gau077","article-title":"Hyperplasia and fibrosis in mice with conditional loss of the TSC2 tumor suppressor in m\u00fcllerian duct mesenchyme-derived myometria","volume":"20","author":"Kaneko-Tarui","year":"2014","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib157","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0300-483X(88)90150-3","article-title":"Uterine abnormalities in rats exposed neonatally to diethylstilbestrol, ethynylestradiol, or clomiphene citrate","volume":"51","author":"Branham","year":"1988","journal-title":"Toxicology"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib158","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/aja.1001860103","article-title":"Histologic, morphometric, and immunocytochemical analysis of myometrial development in rats and mice: II. Effects of DES on development","volume":"186","author":"Brody","year":"1989","journal-title":"Am J Anat"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib159","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mc.20308","article-title":"Developmental exposure to diethylstilbestrol alters uterine gene expression that may be associated with uterine neoplasia later in life","volume":"46","author":"Newbold","year":"2007","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib160","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/01926230290105839","article-title":"Characterization of uterine leiomyomas in CD-1 mice following developmental exposure to diethylstilbestrol (DES)","volume":"30","author":"Newbold","year":"2002","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib161","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.ajog.2004.09.003","article-title":"Pathologic uterine torsion associated with placental abruption, maternal shock, and intrauterine fetal demise","volume":"192","author":"Cook","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib162","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1933719106298401","article-title":"Identification of a sensitive period for developmental programming that increases risk for uterine leiomyoma in Eker rats","volume":"14","author":"Cook","year":"2007","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib163","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1095\/biolreprod53.4.863","article-title":"Ovarian and adrenal contributions to postnatal growth and differentiation of the rat uterus","volume":"53","author":"Branham","year":"1995","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib164","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1210\/endo-109-1-76","article-title":"Uterine responses to estradiol in the neonatal rat","volume":"109","author":"Sheehan","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib165","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1177\/1933719108322440","article-title":"Identification of uterine leiomyoma genes developmentally reprogrammed by neonatal exposure to diethylstilbestrol","volume":"15","author":"Greathouse","year":"2008","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib166","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/1541-7786.MCR-11-0605","article-title":"Environmental estrogens differentially engage the histone methyltransferase EZH2 to increase risk of uterine tumorigenesis","volume":"10","author":"Greathouse","year":"2012","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib167","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pbiomolbio.2015.02.013","article-title":"Phosphorylation of epigenetic \u201creaders, writers and erasers\u201d: Implications for developmental reprogramming and the epigenetic basis for health and disease","volume":"118","author":"Trevino","year":"2015","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib168","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrc3220","article-title":"Developmental reprogramming of cancer susceptibility","volume":"12","author":"Walker","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib169","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1158\/1078-0432.CCR-13-0021","article-title":"Molecular pathways: environmental estrogens activate nongenomic signaling to developmentally reprogram the epigenome","volume":"19","author":"Wong","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib170","doi-asserted-by":"crossref","first-page":"e33284","DOI":"10.1371\/journal.pone.0033284","article-title":"Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma","volume":"7","author":"Navarro","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib171","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/molehr\/gap010","article-title":"Aberrant DNA methylation status in human uterine leiomyoma","volume":"15","author":"Yamagata","year":"2009","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.023_bib172","first-page":"4356","article-title":"Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus","volume":"57","author":"Li","year":"1997","journal-title":"Cancer Res"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216627206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216627206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T02:40:05Z","timestamp":1666492805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028216627206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":172,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0015028216627206"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.08.023","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine-disrupting chemicals and uterine fibroids","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a92016 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}